Home LiteratureArticle Details
PMID: 1519491 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S. Review

Cancer immunotherapy: are the results discouraging? Can they be improved?

Advances in cancer research ·Vol. 59 ·1992-00-00 ·Pages 245-322

Kedar E, Klein E

Abstract

暂无摘要

MeSH Terms
Animals Cytokines/therapeutic use Histocompatibility Antigens/analysis Humans Immunotherapy Immunotherapy, Adoptive Neoplasms/immunology,therapy T-Lymphocytes/immunology
Chemicals
Cytokines Histocompatibility Antigens
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Kedar E
Lautenberg Center for General and Tumor Immunology, Hebrew University-Hadassah Medical School, Jerusalem, Israel.
Klein E
Article Info
Journal
Advances in cancer research
Abbr.
Adv Cancer Res
ISSN
0065-230X
DOI
10.1016/s0065-230x(08)60308-5
Published
1992-00-00
Pages
245-322
Language
English
Region
United States
NLM ID
0370416
Subset
IM
Grants
NCI NIH HHS · 5 RO1 CA 25250-12 · United States
External Links
PubMed source DOI: 10.1016/s0065-230x(08)60308-5 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2